Company Snapshot

Investment Thesis

Zimmer Biomet manufactures orthopedic implants and surgical technologies for knees, hips, spine, and extremities. Procedure recovery, ROSA robotics, and new biologics support mid-single-digit growth with expanding margins.

  • Knee & Hip Scale: Leading share globally with differentiated cementless and personalized implants.
  • Innovation Stack: ROSA robotics, smart implants, and digital care pathways raise ASPs.
  • Margin Playbook: Simplified portfolio and cost programs improve operating leverage.

Strategic Mix

Knee Total knee systems including Persona and NexGen
Hip Primary/revision hips such as Avenir and G7
Extremities & Trauma Shoulder, foot/ankle, sports medicine
Dental, Spine & Other Tether, ROSA, dental implants

Mix mirrors Zimmer Biomet's knee, hip, S.E.T., and dental/spine reporting.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Outpatient Shift

ASC penetration favors vendors with robotics and smart implants.

Portfolio Optimization

Divestitures/free cash support tuck-in acquisitions and buybacks.

Digital Care

MyMobility remote monitoring builds surgeon loyalty.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...